













Estresse oxidativo e parâmetros inflamatórios em pacientes adultos com doença celíaca 
Oxidative stress and inflammatory parameters in adult patients presenting with celiac disease 
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Palavras-chaveDoença celíacaGastroenterologiaParametros inflamatóriosEstresse oxidativoNutrição		Doença celíaca (DC) é uma condição inflamatória crônica do intestino delgado causada por uma resposta imunitária inapropriada ao glúten de trigo, centeio e cevada, com uma prevalência de 1:100 na população caucasiana onde ocorre uma resposta inflamatória e parece envolver elevados níveis de interleucinas. Objetivo: Determinar a presença de estresse oxidativo e inflamação no intestino de pacientes com DC. Método: Para isso realizamos um estudo transversal que incluiu pacientes submetidos a endoscopia gastrointestinal superior. A população do estudo consistiu de 24 casos e 26 controles. Os níveis duodenais de carbonilação proteica, espécies reativas ao ácido tiobarbitúrico (TBARS), bem como a atividade da catalase (CAT) e da superóxido dismutase (SOD) foram mensuradas. Níveis de interleucina (IL), 6, 10 e 8 também foram determinadas no intestisno desses pacientes. A classificação da escala Marsh foi registrada e utilizada como um parâmetro da gravidade da doença. Resultados: Tanto IL-6 e IL-10, mas não IL8, foram aumentados em pacientes com DC quando comparados aos indivíduos saudáveis. Parâmetros de dano oxidativo foram aumentados, enquanto as defesas antioxidantes foram diminuídos em nossa amostra. Níveis de IL6 e atividade da SOD foram relacionados a pontuação Marsh. Conclusão: Diferentes marcadores de inflamação e estresse oxidativo são alteradas no intestino de pacientes com DC, e alguns deles estão relacionados com a gravidade da doença.







Celiac disease (CD) is a chronic small intestinal inflammatory condition caused by an inappropriate immune response to gluten of wheat, rye, barley and malt. The inflammatory process in the gut mucosa causes villous atrophy and bad absorption of nutrients. The disease can have multiple clinical manifestations, from a mild disease to severe forms associated with cancer (Silva and Furlaneto 2010). The disease is common with a prevalence of about 1: 100 in the Caucasian population. The histopathology of CD is characterized by villous blunting, crypt hyperplasia and increased number of intraepithelial lymphocytes. In treated patients gluten challenge induces an accumulation of CD14(+) CD11c(+) dendritic cells  (Beitnes et al. 2012) and this could induce activation of lymphocytes (Ráki et al. 2006). 
This unique inflammatory response seems to involve also the innate immune system since CD patients presents high levels of Toll Like Receptor (TLR) 4 expression and interleukins (IL1, IL6, IL8, and IL17) (Eiró et al. 2012). This kind of response could suggest that microbiota-associated factors may be important in the development of the disease (Kalliomaki et al. 2012). Despite of this a more detailed description of the relationship between cytokines, chemokines and the cellular consequences of inflammation (such as oxidative damage) and DC severity is needed.  
Within this perspective, this research aims to determine the presence of oxidative stress and inflammation in the gut of patients with CD, comparing these markers to healthy patients and histopathological markers of disease severity.  

PATIENTS AND METHODS
This study was approved by the local Ethics committee (529 014/2014).

PATIENTS
It was a transversal study that included patients undergoing upper gastrointestinal (GI) endoscopy in a tertiary hospital from February to June 2014. Adult patients (> 18 years-old) were included if they had complaints suggestive of celiac disease, and the diagnosis was confirmed afterwards by histologic and serologic evaluation as suggested by the American College of Gastroenterology (Rubio-Tapia et al. 2013). In this way, patients were not treated at the moment of sampling. In addition, it was included patients with normal histology who were examined with upper GI endoscopy as part of the routine diagnostic workup.
Duodenal samples were collected during upper GI endoscopy in the same duodenal area taken for histopathological examination. During the histopathological analyses the number of lymphocytes was quantified as well as the Marsh classification recorded. Relevant clinical information was collected directly from the patients or reviewing medical charts.  

METHODS
Oxidative damage to proteins was assessed by determining the carbonyl groups of the sample, based on the reaction with dinitrophenylhydrazine (DNPH). Briefly, proteins were precipitated by addition of 20% trichloroacetic acid, dissolved in guanidine and mixed with DNPH. Protein carbonyls were determined by the absorbance at 370nm and expressed as nmol/mg protein (Levine et al. 1990). As an evidence of lipid peroxidation it was measured thiobarbituric acid reactive species (TBARS) levels in a heated acidic reaction. Briefly, samples were mixed with 10% trichloroacetic acid and of thiobarbituric acid. The solution was boiled for 15 minutes, and the amount of TBARS determined by absorbance at 535 nm (Draper and Hadley 1990). TBARS levels were expressed as MDA equivalents (nmol/mg protein). 
Superoxide dismutase (SOD) activity was measured by the inhibition of autoxidation adrenaline followed spectrophotometrically at 420 nm. A calibration curve was made using as a standard purified SOD in order to calculate the specific activity of SOD present in the samples. A 50% inhibition of the autoxidation was defined as one unit of SOD and the specific activity was represented as units per mg protein (Bannister and Calabrese 1987). The activity of catalase (CAT) was determined by the rate of H2O2 clearance at 240 nm. A unit of CAT is defined as one mole of hydrogen peroxide consumed per minute and the specific activity was reported as units per mg protein (Aebi 1984).
As inflammatory parameters, two cytokines (IL6 and IL10) and one chemokine (IL8) were measured by ELISA kits as recommended by the manufacturer (Peprotech, FUNPEC BRAZIL - SP). The unit of measure was pg/mg protein.
After collecting data, it was designed a database on IBM software Statistical Package for Social Sciences (SPSS) version 21.0. Quantitative variables were expressed as mean and standard deviation and qualitative by frequency and percentages. An association between qualitative variables and the presence of DC was investigated by chi-square and Fisher exact tests. The magnitude of the association was estimated by calculating the odds ratio (OR). The difference between quantitative variables and the presence of DC was investigated by the Mann-Whitney U test, preceded by the Shapiro-Wilk test. Correlation between quantitative variables was determined by Spearman test. The relation of the biomarkers with the Marsh classification was determined by Kruskal-Wallis test. Statistical tests were performed with a significance level α = 0.05 and 95% confidence.

RESULTS
The study population consisted of 50 patients, of whom 24 had a diagnosis of CD. CD patients are significantly older when compared to healthy individuals (Table 1). When it was analyzed the presence of GI symptoms, only the presence of diarrhea was significantly more prevalent in CD patients (Table 1). 
Since it is believed that inflammation have a central role in the pathogenesis of CD it was measured the duodenal levels of IL6, IL10 and IL8. Both IL-6 and IL-10 were increased in CD patients when compared to healthy individuals (Table 2). This was not true IL-8 level.
One of the major consequences of inflammation is oxidative damage, thus it was also determined oxidative damage levels in our sample. Both TBARS and protein carbonyls levels were increased in the duodenum of CD patients (Table 2).  Oxidative damage could also be secondary to an imbalance in antioxidant defenses. In this way, the activity of both CAT and SOD were decreased in patients with CD (Table 2). 
It was further investigate if there is any correlation between histopathological markers of CD severity and inflammatory or oxidative stress biomarkers. There was not any significant correlation between the numbers of lymphocytes in duodenal biopsies and either inflammatory or oxidative parameters (data not shown). In contrast, patients with Marsh score 1 presented higher SOD activity and lower IL6 levels when compared to patients with Marsh score 2 and 3 (Figure 1). In our sample we didn’t have any patient with Marshal score 0 or 4. There was no significant variation between either catalase, IL10 or IL8 when comparing different Marshal scores.      

Discussion
We here demonstrated that both oxidative stress and inflammatory parameters are associated with CD, and both SOD and IL6 levels are related to Marsh score.   
IL-10 is a cytokine with anti-inflammatory properties and plays an important role in inflammation, regulating the immune system (Benjamin et al. 1992). It is secreted by Th2 and T regulatory lymphocytes. CD was originally described as a purely Th1 disease. Probably it involves Th17 and T regulatory lymphocytes as well (Castellanos-Rubios et al. 2009; Frisullo et al., 2009). It is proposed that new therapies to CD involves the suppression of Th1 / Th17 activation by a cross-regulation of the immunological response by concurrent Th2 activation or IL10 production (McSorley et al. 2011). Thus, the observed increased in IL10 levels could be related to an adaptive response to the Th1/Th17 response naturally associated with the development of CD. This is supported by the finding that potential CD patients (those subjects with a normal small intestinal mucosa who are at increased risk of developing CD) show activation of regulatory mechanisms (such as increasing IL10 mRNA levels) and is believed that this is a mechanism to prevent the progression toward a mucosal damage ( (​http:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed​/​24060758​)Borrelli et al. 2013).
IL-6 is a cytokine secreted by T cells and macrophages to stimulate the immune response mainly during infection. It is well known that both Th1 and Th17 lymphocytes are able to secrete IL6, thus it is expected that during CD development there is an increase in gut IL6 levels. As we demonstrated here, Eiró and cols showed that both children and adult CD patients have increased gut levels of several Th1/Th17 related cytokines, including IL6 (Eiró et al. 2012). In treated CD patients a challenge with gliadin induces the expression of IL6 in gut mucosa (Kontokou et al. 1995). Despite of this Medrano and cols. did not find significant correlations between Th17-related genes polymorphisms (including IL6) in CD patients when compared to healthy individuals. (Medrano et al. 2012).
IL-8 is produced by macrophages (​http:​/​​/​en.wikipedia.org​/​wiki​/​Macrophages​) and other cell types such as epithelial cells (​http:​/​​/​en.wikipedia.org​/​wiki​/​Epithelial_cells​), airway smooth muscle cells and endothelial cells. Its main function is to induces the chemotaxis of neutrophils. The role for IL8 during CD development is not well understood.  IL8 is up-regulated, for example, in ulcerative colitis, and the remission of the disease is associated with a normalization of IL8 gene expression ( (​http:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed​/​23135761​)Planell et al. 2103). To the best of our knowledge no study determined IL8 levels in the gut of CD patients. One study found an increase in IL8 gene expression in the gut of CD patients (Eiró et al. 2012), but we are not able to demonstrate any significant difference in protein levels between CD and control patients. IL8 is mainly produced by the innate immune system, and despite some evidence for a role of this response in CD, it is classically related to the activation acquired immune system. Certain gliadin peptides are able to induce an innate immune response probably through the activation of TLRs. TLR activation could then increase the secretion of several cytokines, including IL6 and IL8. A better understanding on the modulation of TLR responses is needed to explain these non-concordant findings (Maiuri et al. 2013). 
In addition to immunogenic effects, gliadin may directly affect intestinal cell structure and function. One of these mechanisms seems to be related to oxidative stress. Gliadin exposure induces an oxidative imbalance, and some markers of oxidative stress, such as 4-hydroxy-2-nonenal and an increase in the oxidised (GSSG)/reduced (GSH) glutathione ratio have been demonstrated in vitro (Luciani et al. 2010). Duodenal biopsies of CD patients also demonstrated markers of oxidative damage, as we here demonstrated (Lavo et al. 1990; Stojiljkovic et al. 2009). Differently from what we found, in children SOD activity seems to be increased in the gut of CD patients, CAT did not change and there was a decrease in the glutathione-related antioxidant defenses (Stojiljkovic et al. 2009). Thus, it seems that oxidative damage could be related to antioxidant defenses alterations, opening the perspective of an antioxidant-based treatment for CD (Calder et al. 2009).

















Figure 1 – Histopathological severity index and its relation with inflammatory and oxidative stress markers. * significantly different from Marsh I, p <0.05
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